Research progress in mechanism of traumatic brain injury affecting speed of fracture healing

Chinese Journal of Traumatology - English Edition

Volumn 10, Issue 6, 2007, Pages 376-380

  Zhao, Xiao Gang ^a   Zhao, Guang Feng ^a   Ma, Yue Feng ^a   Jiang, Guan Yu ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; NERVE GROWTH FACTOR; VASCULOTROPIN;

BODY MASS; BONE DEVELOPMENT; BONE METABOLISM; CALLUS; CELL ACTIVITY; CELL DIFFERENTIATION; CELL DIVISION; CORTICAL BONE; DISEASE SEVERITY; FRACTURE HEALING; FRACTURE IMMOBILIZATION; GENE EXPRESSION; HUMAN; MEDICAL RESEARCH; MITOSIS; NERVE INJURY; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; PERIPHERAL NERVE INJURY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN PURIFICATION; REVIEW; SPINAL CORD INJURY; TRABECULAR BONE; TRANSCRIPTION REGULATION; TRAUMATIC BRAIN INJURY;

EID: 37149047342     PISSN: 10081275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Beeton CA, Chatfield D, Brooks RA, et al. Circulating levels of interleukin-6 and its soluble receptor in patients with head injury and fracture. J Bone Joint Surg Br 2004;86:912-917.
2. Spencer RF. The effect of head injury on fracture healing. A quantitative assessment. J Bone Joint Surg Br 1987; 69:525-528.
3. Morley J, Marsh S, Drakoulakis E, et al. Does traumatic brain injury result in accelerated fracture healing? Injury 2005; 36: 363-368.
4. Pieber K, Schuhfried O, Fialka Moser V. Pulsed electromagnetic fields (PEMF)-results in evidence based medicine. Wien Med Wochenschr 2007;157:34-36.
5. Claes L, Willie B. The enhancement of bone regeneration by ultrasound. Prog Biophys Mol Biol 2007;93:384-398.
6. Schmidmaier G, Lucke M, Schwabe P, et al. Collective review: bioactive implant coated with poly (D, L-lactide) and growth factors IGF-I, TGF-beta 1, or BMP-2 for stimulation of fracture healing. J Long Term Eff Med Implants 2006;16:61-69.
7. Bidner SM, Rubins IM, Desjardins JV, et al. Evidence for a humoral mechanism for enhanced osteogenesis after head injury. J Bone Joint Surg Am 1990;72:1144-1149.
8. Feeney DM, Boyeson MG, Linn RT, et al. Responses to cortical injury. Methodology and local effects of contusions in the rat. Brain Res 1981;211:67-77.
9. Andermahr J. Reduced collagen degradation in polytraumas with traumatic brain injury causes enhanced osteogenesis. J Neurotrauma 2006;23:708-720.
10. Perkins R, Skirving AP. Callus formation and the rate of healing of femoral fractures in patients with head injuries. J Bone Joint Surg Br 1987;69:521-524.
11. Hara-Irie F, Amizuka N, Ozawa H. Immunohistochemical and ultrastructural localization of CGRP-positive nerve fibers at the epiphyseal trabecules facing the growth plate of rat femurs. Bone 1996;18:29-39.
12. Otfinowski J. Heterotopic induction of osteogenesis in the course of neural injury. Patol Pol 1993;44:133-168.
13. Wildburger R, Zarkovic N, Egger G, et al. Basic fibroblast growth factor (bFGF) immunoreactivity as a possible link between head injury and impaired bone fracture healing. Bone Miner 1994;263:30-48.
14. Zhang YD, Zhu PF, Wang ZG, et al. Effect of severe traumatic injury on expression of c-fos and corticotropin-releasing hormone in the hypothalamus of rat. Acta Acad Med Milit Tertiae 2003; 25: 965-967.
15. Kinoshita Y, Ueyama T, Senba E, et al. Expression of c-fos, heat shock protein 70, neurotrophins, and cyclooxygenase-2 mRNA in response to focal cerebral ischemia/reperfusion in rats and their modification by magnesium sulfate. J Neurotrauma 2001;18:435-445.
16. Pascal R, Nassima B, Danielle D, et al. Study of serum factors potentially involved in the pathogenesis of heterotopic bone formation after severe brain injury. Joint Bone Spine 2005;72:146-149.
17. Chodobski A, Szmydynger Chodobska J. Choroid plexus: target for polypeptides and site of their synthesis. Microsc Res Tech 2001;52:65-82.
18. Zhao XG, Zhao GF, Chen YJ, et al. A study on the mechanism of traumatic brain injury affecting the speed of bone fracture healing. Chin J Emerg Med 2007; 16:936-939.
19. Franceschi RT, Xiao G. Regulation of the osteoblast-specific transcription factor, Runx2: responsiveness to multiple signal transduction pathways. J Cell Biochem 2003;88:446-454.
20. Webber CA, Chen YY, Hehr CL. Multiple signaling pathways regulate FGF-2-induced retinal ganglion cell neurite extension and growth cone guidance. Mol Cell Neurosci 2005; 30:37-47.
21. Bryckaert M, Guillonneau X, Hecquet C. Both FGF1 and bcl-x synthesis are necessary for the reduction of apoptosis in retinal pigmented epithelial cells by FGF2: role of the extracellular signal-regulated kinase 2. Oncogene 1999;18:7548-7593.
22. Andoh A, Bamba S, Fujino S. Fibroblast growth factor-2 stimulates interleukin-6 secretion in human pancreatic periacinar myofibroblasts. Pancreas 2004;29:278-283.
23. Zhou FH, Foseer BK, Zhou XF. TNF-alpha mediates p38 MAP kinase activation and negatively regulates bone formation at the injured growth plate in rats. J Bone Miner Res 2006;21:1075-1088.
24. Garcia Maya M, Anderson AA, Kendal CE. Ligand concentration is a driver of divergent signaling and pleiotropic cellular responses to FGF. J Cell Physiol 2006;206:386-393.
25. Park Y, Rangel C, Reynolds MM. Drosophila perlecan modulates FGF and hedgehog signals to activate neural stem cell division. Dev Biol 2003;253:247-257.
26. Vacanti CA, Bonassar LJ. An overview of tissue engineered bone. Clin Orthop Relat Res 1999; (367 Suppl): 375-381.
27. Witte L, Hicklin DJ, Zhu Z. Monoclonal antibodies targeting the VEGF receptor-2 (Flkl/KDR) as an anti-angiogenic therapeutic strategy. Cancer Metastasis Rev 1998; 17: 155-161.
28. Rousseau S, Houle F, Huot J. Integrating the VEGF signals leading to actin-based motility in vascular endothelial cells. Trends Cardiovasc Med 2000; 10:321-327.
29. Yen ML, Su JL, Chien CL. Diosgenin induces hypoxia-inducible factor-1 activation and angiogenesis through estrogen receptor-related phosphatidylinositol 3-kinase/Akt and p38 mitogen-activated protein kinase pathways in osteoblasts. Mol Pharmacol 2005;68: 1061-1073.
30. Takai S, Tokuda H, Hanai Y. Activation of phosphatidylinositol 3-kinase/ Akt limits FGF-2-induced VEGF release in osteoblasts. Mol Cell Endocrinol 2007;267:46-54.
31. Yasuda E, Tokuda H, Ishisaki A. PPAR-gamma ligands up-regulate basic fibroblast growth factor-induced VEGF release through amplifying SAPK/ JNK activation in osteoblasts. Biochem Biophys Res Commun 2005;328:137-143.
32. Pintucci G, Froum S, Pinnell J. Trophic effects of platelets on cultured endothelial cells are mediated by platelet-associated fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor (VEGF). Thromb Haemost 2002;88: 834-842.
33. Sng JC, Taniura H, Yoneda Y. A tale of early response genes. Biol Pharm Bull 2004;27:606-612.
34. Chinenov Y, Kerppola TK. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 2001;20:2438-2452.
35. Herdegen T, Waetzig V. AP-1 proteins in the adult brain: facts and fiction about effectors of neuroprotection and neurodegeneration. Oncogene 2001;20:2424-2437.
36. Hartl M, Bader AG, Bister K. Molecular targets of the oncogenic transcription factor jun. Curr Cancer Drug TARGETS 2003;3:41-45.
37. Jang MH, Chang HK, Shin MC, et al. Effect of Ginseng radix on c-fos expression in the Hippocampus of streptozotoein-induced diabetic rats. J Pharmacol Sci 2003;91:149-152.
38. Czigner A, Mihaly A, Farkas O. Dynamics and regional distribution of c-los protein expression in rat brain after a closed head injury. Int J Mol Med 2004;14:247-252.
39. Awasthi D, Kutz SC, Beuerman R. Early gene expression in the rat cortex after experimental traumatic brain injury and hypotension. Neurosci Lett 2003;345:29-32.
40. Vikhanskaya F, Toh WH, Dulloo I. p73 supports cellular growth through c-Jun-dependent AP-1 transactivation. Nat Cell Biol 2007;9:698-705.
41. Eriksson M, Taskinen M, Leppa S. Mitogen activated protein kinase-dependent activation of c-Jun and c-Fos is required for neuronal differentiation but not for growth and stress response in PC12 cells. J Cell Physiol 2007;210:538-548.
42. Leucht P, Kim JB, Wazen B. Effect of mechanical stimuli on skeletal regeneration around implants. Bone 2007;40: 919-930.
43. Beni SM, Kohen R, Reiter RJ. Melatonin-induced neuroprotection after closed head injury is associated with increased brain antioxidants and attenuated late-phase activation of NF-kappa B and AP-1. FASEB J 2004;18:149-151.
44. Kesemenli CC, Necmioglu S. The role of melatonin as a link between head injury and enhanced osteogenesis. Med Hypotheses 2005; 65: 605-606.
45. Wang XJ, Pei FX, Chi LT, et al. Experimental study of bFGF on the healing process of bone fracture combined with cerebral injury. Chin J Orthop 2003;23:54-56.
46. Grotz MR, Giannoudis PV, Pape HC, et al. Traumatic brain injury and stabilization of long bone fractures: an update. Injury 2004;35:1077-1086.
47. Scalea TM, Boswell SA, Scott JD, et al. External fixation as bridge to intramedullary nailing for patients with multiple injuries and with femur fractures: damage control orthopedics. J Trauma 2000;48:613-623.